Consistent with these findings, knockdown of Msi2 by shRNA in blast crisis CML cells led to a more differentiated cell population and diminished proliferation of the diseased cells [10]. The gene discussed is MSI2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.